GeneDx Holdings (WGS) Receivables (2020 - 2026)
GeneDx Holdings (WGS) reported Receivables of $76.9 million for Q1 2026, up 67.3% year-over-year from $46.0 million in Q1 2025, and up 3.44% quarter-over-quarter from $74.4 million in Q4 2025.
GeneDx Holdings (WGS) Receivables (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Receivables data on file, last reported at $76.9 million in Q1 2026.
- Receivables for Q1 2026 came in at $76.9 million, up 67.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.9 million (up 67.3% YoY), and the FY2025 annual result was $74.4 million, up 97.64% from the prior year.
- Receivables improved to $76.9 million in Q1 2026 per WGS's latest filing, from $74.4 million in the prior quarter.
- Over five years, Receivables peaked at $76.9 million in Q1 2026 and troughed at $445000.0 in Q4 2023.
- A 5-year average of $38.2 million and a median of $38.2 million in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables slumped 98.94% in 2023, then soared 8355.96% in 2024.
- A 5-year view of Receivables shows it stood at $2.2 million in 2022, then sank by 79.85% to $445000.0 in 2023, then soared by 8355.96% to $37.6 million in 2024, then jumped by 97.64% to $74.4 million in 2025, then rose by 3.44% to $76.9 million in 2026.
- Business Quant data shows WGS's Receivables at $76.9 million in Q1 2026, $74.4 million in Q4 2025, and $60.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 1.75 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 10.89 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 3.82 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 922.24 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.82 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 417.60 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 5.16 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 761.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 751.11 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | 76.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.93 Mn |
| Dec 31, 2025 | 74.37 Mn |
| Sep 30, 2025 | 60.94 Mn |
| Jun 30, 2025 | 48.03 Mn |
| Mar 31, 2025 | 45.98 Mn |
| Dec 31, 2024 | 37.63 Mn |
| Sep 30, 2024 | 38.22 Mn |
| Jun 30, 2024 | 25.50 Mn |
| Mar 31, 2024 | 28.15 Mn |
| Dec 31, 2023 | 445,000.00 |
| Sep 30, 2023 | 498,000.00 |
| Jun 30, 2023 | 35.61 Mn |
| Mar 31, 2023 | 35.81 Mn |
| Dec 31, 2022 | 2.21 Mn |
| Sep 30, 2022 | 46.93 Mn |
| Jun 30, 2022 | 50.17 Mn |
| Mar 31, 2022 | 41.39 Mn |
| Dec 31, 2021 | 26.56 Mn |
| Sep 30, 2021 | 21.67 Mn |
| Jun 30, 2021 | 25.01 Mn |